Dr. Giles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8723 Alden Dr
Los Angeles, CA 90048Phone+1 310-423-6257Fax+1 310-423-6287
Education & Training
- Johns Hopkins UniversityFellowship, Rheumatology, 2002 - 2004
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1998 - 2001
- Vanderbilt University School of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 2024 - 2026
- NY State Medical License 2010 - 2024
- MD State Medical License 2004 - 2012
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 25 citationsHeart Rate-corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab.Hitomi Kobayashi, Yasuyuki Kobayashi, Isamu Yokoe, Noboru Kitamura, Atsuma Nishiwaki
The Journal of Rheumatology. 2018-09-01 - 36 citationsShared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease.Brittany N Weber, Jon T Giles, Katherine P Liao
Nature Reviews. Rheumatology. 2023-07-01 - 268 citationsRole of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.Paolo Raggi, Jacques Genest, Jon T. Giles, Katey J. Rayner, Girish Dwivedi
Atherosclerosis. 2018-09-01
Journal Articles
- Amygdalar Metabolic Activity Independently Associates with Progression of Visceral AdipositySteven K Grinspoon, Janet Lo, Jon T Giles, Lisa M Shin, Karestan C Koenen, Roger K Pitman, Ahmed Tawakol, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
- Basic & Clinical Research Conference to Explore Dynamics of Inflammation and Cardiovascular RiskNovember 8th, 2024
- Statin Use Key to Reducing CV Risk in Rheumatoid Arthritis Patients on Tofacitinib: ORAL Surveillance AnalysisSeptember 24th, 2023
- ACR 2022: The Safety of JAK Inhibitors in RheumatologyNovember 26th, 2022
- Join now to see all
Grant Support
- Determinats Of Body Composition In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010
- Determinats Of Body Composition In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: